Trial Profile
Evaluation of the Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous Infusion.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 28 Jun 2011
Price :
$35
*
At a glance
- Drugs Conivaptan (Primary) ; Furosemide; Nesiritide
- Indications Heart failure
- Focus Therapeutic Use
- 09 May 2011 Planned end date changed from 1 Jan 2010 to 1 Feb 2010 as reported by ClinicalTrials.gov.
- 09 May 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 23 Dec 2008 New trial record.